http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014132174-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18 |
filingDate | 2013-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2014132174-A |
titleOfInvention | SOLID NIKOTIN-CONTAINING DOSED FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT |
abstract | 1. A solid pharmaceutical dosage form containing a core sealed with at least one film coating, the core containing nicotine and the film coating containing at least one film-forming polymer and at least one component to reduce one or more organoleptically unpleasant sensations, at least at least one film coating does not contain nicotine and a buffer solution. 2. The dosage form according to claim 1, wherein said core contains a zinc salt or a zinc complex. The dosage form of claim 1, wherein said at least one film coating preferably has a thickness of 10 to 500 microns. The dosage form according to claim 3, wherein said at least one film coating has a thickness of from 20 to 250 microns. The dosage form of claim 3, wherein said at least one film coating has a thickness of 30 to 150 microns. The dosage form of claim 1, wherein said core has a weight of from 50 to 2000 mg. The dosage form according to claim 1, wherein said core has a mass of from 90 to 1200 mg. The dosage form according to claim 1, wherein said film coating has a mass of from 1 to 15% by weight of the core. The dosage form according to claim 1, wherein the organoleptically unpleasant sensation is selected from the group consisting of irritation, causticity, change in taste and loss of taste, burning, tightening, bitterness, tingling, sour taste, salty taste, metallic taste, soapy taste, moldy taste sulfuric taste, acute taste, fatty taste. 10. The dosage form according to claim 1, in which one or more organoleptically unpleasant sensations are caused by nicotine. The dosage form according to claim 1, in which nicotine is presented in a form selected from the group consisting |
priorityDate | 2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.